Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.

Ariadna TibauM Teresa MartínezManuel RamosLuis De La Cruz-MerinoAna SantaballaMiriam O'ConnorNoelia Martínez-JañezFernando MorenoIsaura FernándezJuan Antonio VirizuelaJesús AlarcónJuan de La Haba-RodríguezPedro Sánchez-RoviraCinta Rosa AlbacarCoralia Bueno MuiñoCatherine KellyMaribel CasasSusana BezaresLibertad RosellJoan Albanell

Published in: Therapeutic advances in medical oncology (2023)

Sponsor Study Code: GEICAM/2014-12EudraCT Number: 2015-002437-21ClinTrials.gov reference: NCT02690480.

Keyphrases

patient reported
metastatic breast cancer
phase iii
clinical trial
study protocol
double blind
body composition
placebo controlled